The location of small tumor deposits in the SLN predicts Non-SLN macrometastases in breast cancer patients

European Journal of Surgical Oncology

Volumn 34, Issue 8, 2008, Pages 857-862

  Li, J ^a   Rudas, M ^b   Kemmner, W ^a   Warnick, P ^a   Fischer, J ^a   Gnant, M ^b   Schlag, P M ^a   Bembenek, A ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Breast cancer; Isolated tumor cells; Micrometastases; Non sentinel lymph node involvement; Sentinel lymph node

Indexed keywords

ESTROGEN RECEPTOR; PARAFFIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MICROMETASTASIS; MORPHOLOGY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SENTINEL LYMPH NODE; TUMOR CELL; TUMOR LOCALIZATION; TUMOR VOLUME; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM METASTASIS; RISK FACTORS; SENTINEL LYMPH NODE BIOPSY;

EID: 46949089292     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2007.07.009     Document Type: Article

References (20)

1. Sobin L.H., and Wittekind C. TNM classification of malignant tumors (2002), Wiley-Liss, New York
2. Lyman G., Giuliano A.E., Somerfield M.R., et al. American society of clinical oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23 30 (2005) 7703-7720
3. Kuehn T., Bembenek A., Decker T., et al. A concept for the clinical implementation of sentinel lymph node biopsy in patients with breast carcinoma with special regard to quality assurance. Cancer 103 3 (2005) 451-461
4. Viale G., Malorano E., Mazzarol G., et al. Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer 92 (2001) 1378-1384
5. Chua B., Ung O., Taylor R., Bilous M., Salisbury E., and Boyages J. Treatment implications of a positive sentinel lymph node biopsy for patients with early-stage breast carcinoma. Cancer 92 7 (2001) 1769-1774
6. Rutledge H., Davis J., Chiu R., et al. Sentinel node micrometastasis in breast carcinoma may not be an indication for complete axillary dissection. Mod Pathol 18 6 (2005) 762-768
7. Fournier K., Schiller A., Perry R., and Laronga C. Micrometastasis in the sentinel lymph node of breast cancer dose not mandate completion axillary dissection. Ann Surg 239 (2004) 859-865
8. Cserni G., Bianchi S., Boecker W., et al. Improving the reproducibility of diagnosing micrometastases and isolated tumor cells. Cancer 103 2 (2005) 358-367
9. Rao R.S., Taylor J., Palmer J., and Jennings W.C. Breast cancer patients pseudometastasis in a sentinel lymph node with cytokeratine-positive debris. Breast J 11 (2005) 134-137
10. Hermanek P., Hutter R.V., Sobin L.H., and Wittekind C. Internatinternonal Union Against Cancer. Classification of isolated tumor cells and micrometastasis. Cancer 86 12 (1999) 2668-2673
11. Dewar D.J., Newell B., Green M.A., Topping A.P., Powell B.W.E.M., and Cook M.G. The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. J Clin Oncol 22 (2004) 3345-3349
12. Schrenk P., Konstantiniuk P., Wolfl S., et al. Prediction of non-sentinel lymph node status in breast cancer patients with a micrometastatic sentinel node. Br J Surg 92 6 (2005) 707-713
13. Van Zee K.J., Manasseh D.M., Bevilacqua J.L., et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 10 10 (2003) 1140-1151
14. Den Bakker M.A., van Weeszenberg A., de Kanter A.Y., et al. Non-sentinel lymph node involvement in patients with breast cancer and sentinel node micrometastasis; too early to abandon axillary clearance. J Clin Pathol 55 (2002) 932-935
15. Rahusen F.D., Torrenga H., van Diest P.J., et al. Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer. Arch Surg 136 (2001) 1059-1063
16. Kamat V., Giuliano R., Dauway E.L., et al. Characteristics of the sentinel node in breast cancer predict further involvement of higher-echolon nodes in the axilla. Arch Surg 136 (2001) 688-692
17. Weiser M.R., Montgomery L.L., Tan L.K., et al. Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes. Ann Surg Oncol 8 2 (2001) 145-149
18. Schirrmeister H., Kotzerke J., Vogl F., et al. Prospective evaluation of factors influencing success rates of sentinel node biopsy in 814 breast cancer patients. Cancer Biother Radiopharm 19 6 (2004) 784-790
19. Veronesi U., Paganelli G., Viale G., et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349 6 (2003) 546-553
20. Park J., Fey J.V., Naik A.M., Borgen P.I., Van Zee K.J., and Cody H.S. A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram. Ann Surg 245 3 (2007) 462-468